CGI-S at baseline was also associated with categorical improvement at 6 months, however with better odds for improvement in patients with low CGI-S at baseline.
As hypothesized, HEE-EOI at baseline was also associated with worse fatigue severity, but, contrary to predictions, not disability reported at follow-up (see Table 3).
LEA at baseline was also associated with increased risk during follow-up of ESRD, myocardial infarction, all-cause mortality, and specifically, with mortality due to cardiovascular and infectious diseases.
Similarly, IL-4 production in supernatant of PBMC cultured with PPD at baseline was also associated with an increased risk of experiencing a decline in CD4+ cell count to < 350/μL during ART interruption (Table 2).
Valgus alignment at baseline was also associated with a nearly fivefold increase in the odds of lateral progression; the severity of varus correlated with medial joint space loss (r = 0.52, 95% CI = 0.40 0.62 in dominant knees), and the severity of valgus correlated with subsequent lateral joint space loss (r = 0.35, 95% CI = 0.21 0.47 in dominant knees).
a numbers do not always add up to total due to missing information in few items b Fisher's Exact Test c (neuropathological complications not included as difficult to assess in the context of this study in primary care) The physicians' assessment of patient compliance during baseline was also associated with an increased mortality (see table 3).
Higher insight at baseline was also associated with milder clinical severity (SCC between the SUMD items and the CGI score ranged from 0.29 to 0.39, p < 0.0001; Table 2) and better global functioning (SCC between the items of the SUMD and the GAF score ranged from −0.31 to −0.34, p < 0.0001; Table 2).
Therapeutic relationship, adherence and baseline GAF were also associated with 1-year GAF.
